Siemens Fonds Invest GmbH Acquires New Position in DocuSign, Inc. (NASDAQ:DOCU)

Siemens Fonds Invest GmbH bought a new stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 8,580 shares of the company's stock, valued at approximately $772,000.

A number of other institutional investors also recently modified their holdings of the business. FMR LLC lifted its holdings in shares of DocuSign by 178.2% in the fourth quarter. FMR LLC now owns 6,101,024 shares of the company's stock worth $548,726,000 after acquiring an additional 3,908,139 shares during the last quarter. American Century Companies Inc. lifted its holdings in shares of DocuSign by 18.5% in the fourth quarter. American Century Companies Inc. now owns 5,315,459 shares of the company's stock worth $478,072,000 after acquiring an additional 831,611 shares during the last quarter. Jericho Capital Asset Management L.P. lifted its holdings in shares of DocuSign by 34.0% in the fourth quarter. Jericho Capital Asset Management L.P. now owns 4,754,753 shares of the company's stock worth $427,642,000 after acquiring an additional 1,205,500 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in shares of DocuSign by 4.9% in the fourth quarter. Renaissance Technologies LLC now owns 4,363,292 shares of the company's stock worth $392,434,000 after acquiring an additional 205,304 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of DocuSign by 7.2% in the fourth quarter. Geode Capital Management LLC now owns 3,732,363 shares of the company's stock worth $335,147,000 after acquiring an additional 249,179 shares during the last quarter. Institutional investors own 77.64% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Robert W. Baird set a $93.00 target price on shares of DocuSign in a report on Friday, March 14th. Jefferies Financial Group dropped their price objective on shares of DocuSign from $115.00 to $105.00 and set a "buy" rating for the company in a report on Monday, March 31st. JPMorgan Chase & Co. upgraded shares of DocuSign from an "underweight" rating to a "neutral" rating and raised their price objective for the company from $70.00 to $75.00 in a report on Monday, March 10th. UBS Group dropped their price objective on shares of DocuSign from $90.00 to $85.00 and set a "neutral" rating for the company in a report on Thursday, April 17th. Finally, Wedbush reiterated a "neutral" rating and issued a $100.00 price objective on shares of DocuSign in a report on Friday, March 14th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $92.46.

Insider Transactions at DocuSign

In other news, Director Teresa Briggs sold 534 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $87.41, for a total transaction of $46,676.94. Following the completion of the sale, the director now owns 8,270 shares of the company's stock, valued at $722,880.70. This trade represents a 6.07% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Robert Chatwani sold 15,706 shares of DocuSign stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $83.19, for a total transaction of $1,306,582.14. Following the completion of the sale, the insider now directly owns 76,842 shares of the company's stock, valued at approximately $6,392,485.98. The trade was a 16.97% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 47,851 shares of company stock valued at $3,912,239 in the last quarter. 1.01% of the stock is currently owned by company insiders.

DocuSign Price Performance

NASDAQ DOCU traded up $0.59 during mid-day trading on Monday, reaching $89.20. 2,055,752 shares of the stock were exchanged, compared to its average volume of 2,778,435. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The stock has a 50 day simple moving average of $81.67 and a 200-day simple moving average of $86.06. The stock has a market cap of $18.06 billion, a P/E ratio of 18.39, a P/E/G ratio of 6.94 and a beta of 1.21.

DocuSign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, March 13th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.84 by $0.02. The company had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The company's quarterly revenue was up 9.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.76 EPS. Sell-side analysts anticipate that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.